Cargando…
Mutated genes on ctDNA detecting postoperative recurrence presented reduced neoantigens in primary tumors in colorectal cancer cases
The detection and sequencing of the mutated ctDNA is one of the irreplaceable clinical measures in the postoperative management of colorectal cancer (CRC) cases. However, we are curious to comprehend the essential traits of mutated genes comprising metastatic sites out of whole mutated genes in prim...
Autores principales: | Nagayama, Satoshi, Kobayashi, Yuta, Fukunaga, Mitsuko, Sakimura, Shotaro, Sugimachi, Keishi, Sasaki, Shin, Masuda, Takaaki, Mafune, Ken-ichi, Oshima, Masanobu, Shibata, Tatsuhiro, Suzuki, Yutaka, Mimori, Koshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873919/ https://www.ncbi.nlm.nih.gov/pubmed/36693917 http://dx.doi.org/10.1038/s41598-023-28575-3 |
Ejemplares similares
-
Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases
por: Sakimura, Shotaro, et al.
Publicado: (2021) -
Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy
por: Sugimachi, Keishi, et al.
Publicado: (2018) -
Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients
por: Sugimachi, Keishi, et al.
Publicado: (2015) -
Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence
por: Ueda, Masami, et al.
Publicado: (2016) -
GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor‐suppressor gene TGFβR2 in colorectal cancer
por: Nambara, Sho, et al.
Publicado: (2019)